The reiteration of a Buy rating and maintenance of a $60 price target by a reputable analyst firm like HC Wainwright & Co. is likely to instill confidence among investors and could lead to a positive short-term impact on Arcturus Therapeutics' stock price. Analyst ratings, especially those that are positive, tend to influence investor sentiment and can lead to stock price movements.